Oncologists Global Market Report 2024

Description

“Oncologists Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncologists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncologists? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The oncologists market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Cancer Diagnostics and Treatment: Cancer Diagnostics; Cancer Treatment
2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head and Neck Cancer; Prostate Cancer; Other Indications
3) By End Use: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia; Other End Uses
Companies Mentioned: Abramson Cancer Center; MD Anderson Cancer Center of the University of Texas; Lilavati Hospital & Research Centre; Mount Elizabeth Hospital; Mount Miriam Cancer Hospital
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Oncologists are a specialized type of healthcare practitioner focused on the diagnosis and treatment of cancer. They play a crucial role in evaluating patients, diagnosing cancer, and recommending appropriate treatments, actively participating in the comprehensive care of cancer patients.

The primary areas of focus for oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics involve testing procedures designed to confirm the presence of cancer and identify the specific tumor type. Common cancer types include lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, and prostate cancer. Oncologists work in various healthcare settings, including hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia, and other related institutions.

The oncologists market research report is one of a series of new reports from The Business Research Company that provides oncologists market statistics, including oncologists industry global market size, regional shares, competitors with an oncologists market share, detailed oncologists market segments, market trends and opportunities, and any further data you may need to thrive in the oncologists industry. This mobile wallet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncologists market size has grown steadily in recent years. It will grow from $19.35 billion in 2023 to $19.19 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth observed in the historical period can be attributed to factors such as the increasing incidence of cancer, advancements in therapeutic approaches, a growing aging population, development of healthcare infrastructure, and the implementation of awareness and early detection programs.

The oncologists market size is expected to see steady growth in the next few years. It will grow to $22.72 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of precision medicine and personalized therapies, advancements in therapeutic modalities, global collaboration in oncology, shifts in epidemiology and new challenges, as well as influences from healthcare policy and economic factors. Major trends in this period include advancements in immunotherapy, the integration of precision medicine, expansion of telemedicine, a shift towards data-driven decision-making, the adoption of collaborative care models, and an increased focus on patient-centric care.

The oncologists' market is anticipated to experience growth due to the increasing prevalence of cancer. Cancer is characterized by the uncontrolled growth and spread of a few body cells, and its prevalence is determined by the number of new cases within a specific population during a given period. Oncologists, specialized healthcare practitioners focusing on cancer diagnosis and treatment, play a crucial role in examining patients, diagnosing cancer, and identifying suitable treatment options. According to the 2021 American Cancer Society report, there were 1.8 million new cancer cases diagnosed in 2020, reflecting a significant increase from previous years. The National Cancer Institute reported a 43% rise in new cancer cases to 1,806,590 in September 2020. Hence, the growing prevalence of cancer is a driving force behind the oncologists' market.

The growth of the aging population is expected to be a significant factor supporting the expansion of the oncologists' market. An aging population, comprising individuals aged 60 and above, is more susceptible to cancer as the risk of cancer increases with age. The demand for oncologists rises with the growing prevalence of cancer in the elderly population. According to the World Health Organization, by 2030, 1 in 6 people globally will be aged 60 or above. The number of elderly individuals reached 1.4 billion in 2020, and by 2050, it is projected to more than double, reaching 2.1 billion. Therefore, the increasing size of the aging population is expected to have a positive impact on the oncologists' market in the forecast period.

A key trend in the oncologists' market is the focus on new innovations, with major companies developing digital solutions to enhance their positions. For instance, in December 2021, The Roche Group introduced its latest digital solution, the 'Navify Oncology Hub,' designed to simplify clinical workflows and improve decision support for oncology care teams and oncologists. This solution aids in aggregating and organizing patient data across various IT systems within an institution.

Major companies in the oncologists' market are also establishing new collaborative networks to advance research and development efforts. In September 2023, Amgen launched the 'Amgen Partners of Choice' network, bringing together its oncology research and development experts with clinical leaders at eight global research centers. The network, part of Amgen's mission to enhance care through partnerships, fosters academic collaboration to advance innovative treatment options for patients with significant unmet needs.

In April 2021, Siemens Healthineers AG acquired Varian Medical Systems, Inc. for an undisclosed amount, enhancing resources to support cancer patients across major clinical pathways. The acquisition aims to address the rising rates of cancer by providing personalized, data-driven diagnosis and cancer care. Varian Medical Systems, Inc., a US-based company, is a provider of radiation oncology software and treatments.

Major companies operating in the oncologists market report are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charite - Universitatsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., Aegerion Pharmaceuticals Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Celgene Corporation, Gilead Sciences Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc

North America was the largest region in the oncologists market in 2023. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncologists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11192

1. Executive Summary

2. Oncologists Market Characteristics

3. Oncologists Market Trends And Strategies

4. Oncologists Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Oncologists Market Size and Growth

5.1. Global Oncologists Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Oncologists Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Oncologists Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oncologists Market Segmentation

6.1. Global Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer Diagnostics
Cancer Treatment
6.2. Global Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lungs Cancer
Colorectal Cancer
Breast Cancer
Liver Cancer
Bladder Cancer
Head and Neck Cancer
Prostate Cancer
Other Indications
6.3. Global Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Diagnostic Laboratories
Diagnostic Imaging Centers
Specialty Clinics
Academia
Other End Uses

7. Oncologists Market Regional And Country Analysis

7.1. Global Oncologists Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Oncologists Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oncologists Market

8.1. Asia-Pacific Oncologists Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oncologists Market

9.1. China Oncologists Market Overview
9.2. China Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oncologists Market

10.1. India Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oncologists Market

11.1. Japan Oncologists Market Overview
11.2. Japan Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oncologists Market

12.1. Australia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oncologists Market

13.1. Indonesia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oncologists Market

14.1. South Korea Oncologists Market Overview
14.2. South Korea Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oncologists Market

15.1. Western Europe Oncologists Market Overview
15.2. Western Europe Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oncologists Market

16.1. UK Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oncologists Market

17.1. Germany Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oncologists Market

18.1. France Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oncologists Market

19.1. Italy Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oncologists Market

20.1. Spain Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oncologists Market

21.1. Eastern Europe Oncologists Market Overview
21.2. Eastern Europe Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oncologists Market

22.1. Russia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oncologists Market

23.1. North America Oncologists Market Overview
23.2. North America Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oncologists Market

24.1. USA Oncologists Market Overview
24.2. USA Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oncologists Market

25.1. Canada Oncologists Market Overview
25.2. Canada Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oncologists Market

26.1. South America Oncologists Market Overview
26.2. South America Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oncologists Market

27.1. Brazil Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oncologists Market

28.1. Middle East Oncologists Market Overview
28.2. Middle East Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oncologists Market

29.1. Africa Oncologists Market Overview
29.2. Africa Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oncologists Market Competitive Landscape And Company Profiles

30.1. Oncologists Market Competitive Landscape
30.2. Oncologists Market Company Profiles
- 30.2.1. Abramson Cancer Center
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. MD Anderson Cancer Center of the University of Texas
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Lilavati Hospital & Research Centre
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Mount Elizabeth Hospital
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Mount Miriam Cancer Hospital
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Oncologists Market Competitive Benchmarking

32. Global Oncologists Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Oncologists Market

34. Oncologists Market Future Outlook and Potential Analysis

34.1 Oncologists Market In 2028 - Countries Offering Most New Opportunities
34.2 Oncologists Market In 2028 - Segments Offering Most New Opportunities
34.3 Oncologists Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer